His primary areas of investigation include Internal medicine, Endocrinology, Cancer research, Receptor and Molecular biology. In his work, Biochemistry and Cytokine is strongly intertwined with Cell biology, which is a subfield of Internal medicine. His Endocrinology research is multidisciplinary, incorporating perspectives in Cell culture, Autocrine signalling, Epithelium, Apoptosis and Cellular localization.
His Cancer research research is multidisciplinary, relying on both Cancer, Breast cancer, Metastasis, Cell growth and Estrogen receptor alpha. His Receptor research includes elements of Cerebral cortex, Growth hormone receptor, In situ hybridization and Cerebellum. Within one scientific family, Peter E. Lobie focuses on topics pertaining to Phosphorylation under Molecular biology, and may sometimes address concerns connected to Chinese hamster ovary cell, Transcription factor and Kinase.
His scientific interests lie mostly in Cancer research, Internal medicine, Endocrinology, Autocrine signalling and Cell growth. His work carried out in the field of Cancer research brings together such families of science as Cancer, Breast cancer, Metastasis, Cell and Apoptosis. His work deals with themes such as Molecular biology and Doxorubicin, which intersect with Apoptosis.
Peter E. Lobie has included themes like Receptor, Cell culture and Signal transduction in his Endocrinology study. Peter E. Lobie combines subjects such as Human growth hormone and Paracrine signalling with his study of Autocrine signalling. The study incorporates disciplines such as Trefoil factor 3, Epithelial–mesenchymal transition, Cell migration, Cancer stem cell and Matrigel in addition to Cell growth.
His primary scientific interests are in Cancer research, Cancer, Breast cancer, Cell growth and Protein kinase B. His study in Cancer research is interdisciplinary in nature, drawing from both Trefoil factor 3, Cancer cell, Downregulation and upregulation, Metastasis and Phosphorylation. His Phosphorylation research also works with subjects such as
His biological study spans a wide range of topics, including Autophagy, Precision medicine, Computational biology and Kinase. Breast cancer is a subfield of Internal medicine that he studies. His study looks at the relationship between Cell growth and topics such as Cell migration, which overlap with Paracrine signalling, Lung cancer and Gene silencing.
Peter E. Lobie mostly deals with Cancer research, Cancer, Metastasis, Apoptosis and Phosphorylation. The Angiogenesis research Peter E. Lobie does as part of his general Cancer research study is frequently linked to other disciplines of science, such as Complement factor I, therefore creating a link between diverse domains of science. His work in Angiogenesis addresses issues such as Vascular endothelial growth factor, which are connected to fields such as Cell culture.
The various areas that Peter E. Lobie examines in his Cancer study include Autophagy and Inhibitor of apoptosis. Peter E. Lobie has researched Metastasis in several fields, including Gene knockdown, Cell growth, PSMB2, Carcinogenesis and Breast cancer. His Apoptosis research integrates issues from Molecular biology and In vitro.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signal transduction via the growth hormone receptor.
Tao Zhu;Eyleen L.K Goh;Ralph Graichen;Ling Ling.
Cellular Signalling (2001)
Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems.
Peter E. Lobie;Winrich Breipohl;Juanita García Aragón;Michael J. Watesr.
Localization and ontogeny of growth hormone receptor gene expression in the central nervous system.
Peter E. Lobie;Juanita García-Aragón;David T. Lincoln;Ross Barnard.
Developmental Brain Research (1993)
MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression
Xiangjun Kong;Gaopeng Li;Yan Yuan;Yan He.
PLOS ONE (2012)
Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/stat 5
Timothy J.J. Wood;Daniel Sliva;Peter E. Lobie;Tony J. Pircher.
Journal of Biological Chemistry (1995)
Cellular expression of growth hormone and prolactin receptors in human breast disorders
Hichem C. Mertani;Tomas Garcia-Caballero;Anne Lambert;Francoise Gérard.
International Journal of Cancer (1998)
Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA.
C Möller;A Hansson;B Enberg;P E Lobie.
Journal of Biological Chemistry (1992)
Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.
Xin Zhang;Tao Zhu;Yong Chen;Hichem C. Mertani.
Journal of Biological Chemistry (2003)
Growth hormone receptor expression in the rat gastrointestinal tract.
Peter E. Lobie;Winrich Breipohl;Michael J. Waters.
Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development?
J. Garcia-Aragon;P. E. Lobie;G. E. O. Muscat;K. S. Gobius.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: